Changing Economics of Medical Technology

Inbunden, Engelska, 1991

AvInstitute of Medicine,Committee on Technological Innovation in Medicine,Ethan A. Halm,Annetine C. Gelijns

1 729 kr

Tillfälligt slut

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policies--as well as the involvement of numerous government agencies--affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

Produktinformation

Utgivningsdatum1991-01-01
Mått152 x 229 x 21 mm
Vikt454 g
FormatInbunden
SpråkEngelska
Antal sidor224
FörlagNational Academies Press
ISBN9780309044912

Tillhör följande kategorier

1 Front Matter; 2 1. An Introduction to the Changing Economics of Technological Innovation in Medicine; 3 2. The Diffusion of New Technology: Costs and Benefits to Health Care; 4 3. The Changing Economics of Pharmaceutical Research and Development; 5 4. Public Policy and Access to New Drugs: The Case of Cancer Chemotherapy; 6 5. The Impact of Public Policy on Medical Device Innovation: A Case of Polyintervention; 7 6. The Dynamics of Medical Device Innovation: An Innovator's Perspective; 8 7. Reimbursement and the Dynamics of Surgical Procedure Innovation; 9 8. European Policies Influencing Pharmaceutical Innovation; 10 9. Medical Device Innovation and Public Policy in the European Economic Community; 11 10. Japan's Pharmaceutical Industry Postwar Evolution; 12 Appendix A: The Impact of Regulation and Reimbursement on Pharmaceutical Innovation; 13 Appendix B: The Economics of Pharmaceutical Research and Development: An Industry Persepective; 14 Appendix C: Contributors; 15 Index

Mer från samma författare

To Err Is Human

Institute of Medicine, Committee on Quality of Health Care in America, Molla S. Donaldson, Janet M. Corrigan, Linda T. Kohn

Häftad, 2000

649 kr

From Neurons to Neighborhoods

National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson

Häftad, 2012

369 kr

Nursing and Nursing Education

Institute of Medicine, Division of Health Care Services

Häftad, 1983

2 279 kr

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad, 1984

2 599 kr

New Vaccine Development

Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health

Häftad, 1986

2 509 kr

Social and Built Environment in an Older Society

Institute of Medicine, Committee on an Aging Society

Häftad, 1988

2 269 kr

Physician Staffing for the VA

Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb

Häftad, 1991

1 639 kr